These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37203753)

  • 61. A meta-epidemiological study to examine the association between bias and treatment effects in neonatal trials.
    Bialy L; Vandermeer B; Lacaze-Masmonteil T; Dryden DM; Hartling L
    Evid Based Child Health; 2014 Dec; 9(4):1052-9. PubMed ID: 25504975
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Is the evaluation of risk of bias in periodontology and implant dentistry comprehensive? A systematic review.
    Faggion CM; Listl S; Alarcón MA
    J Clin Periodontol; 2015 May; 42(5):488-94. PubMed ID: 25809114
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of Risks of Bias in Addiction Medicine Randomized Controlled Trials.
    Wayant C; Tritz D; Horn J; Crow M; Vassar M
    Alcohol Alcohol; 2021 Apr; 56(3):284-290. PubMed ID: 32808009
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical trials in COVID-19 management & prevention: A meta-epidemiological study examining methodological quality.
    Honarmand K; Penn J; Agarwal A; Siemieniuk R; Brignardello-Petersen R; Bartoszko JJ; Zeraatkar D; Agoritsas T; Burns K; Fernando SM; Foroutan F; Ge L; Lamontagne F; Jimenez-Mora MA; Murthy S; Yepes-Nuñez JJ; Vandvik PO; Ye Z; Rochwerg B
    J Clin Epidemiol; 2021 Nov; 139():68-79. PubMed ID: 34274489
    [TBL] [Abstract][Full Text] [Related]  

  • 65. NCBI disease corpus: a resource for disease name recognition and concept normalization.
    Doğan RI; Leaman R; Lu Z
    J Biomed Inform; 2014 Feb; 47():1-10. PubMed ID: 24393765
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Key concepts in clinical epidemiology: addressing and reporting sources of bias in randomized controlled trials.
    Kotz D; West R
    J Clin Epidemiol; 2022 Mar; 143():197-201. PubMed ID: 34571193
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Methodological Quality and Risk of Bias Assessment of Cardiovascular Disease Research: Analysis of Randomized Controlled Trials Published in 2017.
    Baasan O; Freihat O; Nagy DU; Lohner S
    Front Cardiovasc Med; 2022; 9():830070. PubMed ID: 35369336
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intra-articular hyaluronic acid injection in treating knee osteoarthritis: assessing risk of bias in systematic reviews with ROBIS tool.
    Xing D; Wang B; Zhang W; Yang Z; Hou Y; Chen Y; Lin J
    Int J Rheum Dis; 2017 Nov; 20(11):1658-1673. PubMed ID: 29044993
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Risk of bias in randomized controlled trials of psychological treatments for bulimia nervosa and binge eating.
    Trevizo JP; Hay P; Swardfager W; Cogo-Moreira H
    Ann Epidemiol; 2018 Sep; 28(9):625-628.e1. PubMed ID: 30033037
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Assessing risk of bias in human environmental epidemiology studies using three tools: different conclusions from different tools.
    Eick SM; Goin DE; Chartres N; Lam J; Woodruff TJ
    Syst Rev; 2020 Oct; 9(1):249. PubMed ID: 33121530
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Degree of Risk of Bias in Randomized Controlled Trials: Does It Have an Impact on Root Coverage Outcomes?
    Tattan M; Moore KS; Chambrone L; Avila-Ortiz G; Elangovan S
    J Evid Based Dent Pract; 2021 Mar; 21(1):101526. PubMed ID: 34051960
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Use and reporting of risk of bias tools in 825 systematic reviews of acupuncture: a cross-sectional study.
    Long Y; Wang X; Xiao W; Chen R; Guo Q; Liu J; Shao R; Huang J; Du L
    Acupunct Med; 2021 Aug; 39(4):318-326. PubMed ID: 32811166
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The fragility of randomized trial outcomes underlying management of dyspepsia and Helicobacter pylori infections.
    Meyer C; Bowers A; Tritz D; Fuller K; Wayant C; Cook C; Torgerson T; Som M; Vassar M
    Int J Evid Based Healthc; 2020 Mar; 18(1):125-137. PubMed ID: 31567602
    [TBL] [Abstract][Full Text] [Related]  

  • 74. How do systematic reviews incorporate risk of bias assessments into the synthesis of evidence? A methodological study.
    Katikireddi SV; Egan M; Petticrew M
    J Epidemiol Community Health; 2015 Feb; 69(2):189-95. PubMed ID: 25481532
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of standardized training on the reliability of the Cochrane risk of bias assessment tool: a study protocol.
    da Costa BR; Resta NM; Beckett B; Israel-Stahre N; Diaz A; Johnston BC; Egger M; Jüni P; Armijo-Olivo S
    Syst Rev; 2014 Dec; 3():144. PubMed ID: 25495124
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A risk of bias instrument for non-randomized studies of exposures: A users' guide to its application in the context of GRADE.
    Morgan RL; Thayer KA; Santesso N; Holloway AC; Blain R; Eftim SE; Goldstone AE; Ross P; Ansari M; Akl EA; Filippini T; Hansell A; Meerpohl JJ; Mustafa RA; Verbeek J; Vinceti M; Whaley P; Schünemann HJ;
    Environ Int; 2019 Jan; 122():168-184. PubMed ID: 30473382
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Assessment of risk of bias in quasi-randomized controlled trials and randomized controlled trials reported in the
    Kim JH; Kim TK; In J; Lee DK; Lee S; Kang H
    Korean J Anesthesiol; 2017 Oct; 70(5):511-519. PubMed ID: 29046770
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Systematic metareview of prediction studies demonstrates stable trends in bias and low PROBAST inter-rater agreement.
    Langenhuijsen LFS; Janse RJ; Venema E; Kent DM; van Diepen M; Dekker FW; Steyerberg EW; de Jong Y
    J Clin Epidemiol; 2023 Jul; 159():159-173. PubMed ID: 37142166
    [TBL] [Abstract][Full Text] [Related]  

  • 79. New directions in biomedical text annotation: definitions, guidelines and corpus construction.
    Wilbur WJ; Rzhetsky A; Shatkay H
    BMC Bioinformatics; 2006 Jul; 7():356. PubMed ID: 16867190
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inter-rater reliability and validity of risk of bias instrument for non-randomized studies of exposures: a study protocol.
    Jeyaraman MM; Al-Yousif N; Robson RC; Copstein L; Balijepalli C; Hofer K; Fazeli MS; Ansari MT; Tricco AC; Rabbani R; Abou-Setta AM
    Syst Rev; 2020 Feb; 9(1):32. PubMed ID: 32051035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.